The following are the ingredient lists, warnings and side effects for vaccines currently scheduled to be administered to populations worldwide for the H1N1 swine flu.

Not one scientific study has ever established the long-term safety of adjuvants and none have ever been approved for use in vaccines for humans.

International Chart of ALL H1N1 Vaccines By Country

2009 H1N1 Vaccines FDA-Approved in the U.S.
including Ingredients and Toxicity (REPORT)

H1N1 Vaccines' Immunotoxity, Neurotoxicity,
Sterility and Carcinogenic Ingredients (REPORT)

Research Citations Linking Vaccines To Disease (REF)

9 Questions That Stump Every
Pro-Vaccine Advocate and Their Claims (REPORT)

APPROVED FOR USE IN CANADA
GlaxoSmithKline Arepanrix™ H1N1
AS03-Adjuvanted Pandemic Influenza Vaccine (PDF)

Analysis of Arepanrix H1N1 Vaccine
and How It Can Harm Your Health (REPORT)

APPROVED FOR USE IN THE UK/EUROPE
Assessment Report For GlaxoSmithKline
Pandemrix based on application to EMEA (PDF)

Pandemic H1N1 Vaccines Authorized EMEA (PDF)

APPROVED FOR USE IN THE UK/EUROPE
Product Characteristics of Pandemrix H1N1 Vaccine 2009 (PDF)

Focetria H1N1 Adjuvanted EMEA 2009

GlaxoSmithKline Fluarix 2009-2010 Formula (PDF)

APPROVED FOR USE IN THE UNITED STATES
Sanofi-Pasteur Influenza A-2009 H1N1 Vaccine
Package Insert Based On 1980 Approval for Fluzone (PDF)

Novartis FLUVIRIN Latest 2009 Package Insert (PDF)

APPROVED FOR USE IN THE UNITED STATES
Novartis A-H1N1 2009 Monovalent Vaccine Package
Insert Based On 1980 Approvalfor Fluvirin (PDF)

APPROVED FOR USE IN THE UNITED STATES
Intranasal Spray MedImmune A-H1N1 Vaccine
Package Insert Based On 2003 Approval for FluMist (PDF)

APPROVED FOR USE IN THE UNITED STATES
FLUARIX 2009 Latest Package Insert (PDF)

APPROVED FOR USE IN THE UNITED STATES
ID Biomedical Corporation 2009 H1N1 Monovalent Vaccine (PDF)

APPROVED FOR USE IN THE UNITED STATES
CSL Influenza A-H1N1 2009 Vaccine Package
Insert Based On 2007 Approval for Afluria (PDF)

APPROVED FOR USE IN AUSTRALIA
CSL Product Information of PANVAX H1N1 Vaccine 2009 (PDF)

CSL 2009 Latest Afluria Package Insert (PDF)

BAXTER Patent Application Citing
Monkey Kidney (VERO) Cell Culture (PDF)

* Download PDF on H1N1 Flu Vaccines

Chemicals and Package Inserts of Common Vaccines

• Are Populations Being Primed
  For Nano-Microchips Inside Vaccines?
  
  
• More articles in the Flu Pandemic Archive
  
  
• H1N1 Expert Says Scientists Are Clueless
  About Immune Reactions to Vaccinations
• 15 Important Reasons Why You Shouldn't
  Vaccinate Your Children Against The Flu
• Vaccines Are One Big Experiment Causing
  Hundreds of Diseases In The Modern World
• Drug Industry Investigator Launches FBI
  Request To Investigate H1N1 Swine Flu
• H1N1 Vaccine Shortage Prompts Backtrack:
  One Vaccine is Suddenly Protective Now
• Junk Science and Contradictions Dominate
  WHO Pandemic Statements and Policies
  
• How To Orchestrate An Effective
  Pandemic Campaign For The Flu
• Solutions To Help Those
  Forced To Take The H1N1 Vaccine
  
• Vaccines Are Producing
  The Pandemic, Not The Flu
• The H1N1 Vaccine Is A Much Greater
  Risk To Your Health Than The Flu Itself
• First Target of Vaccination Campaigns:
  Pregnant Women And Unborn Children
• Governments Massively Stockpiling
  Vaccines For Campaigns This Fall
• Governments Intensifying Fearmongering
  Strategies For Mass H1N1 Vaccinations
• Mass Vaccinations Being Prepared
  For WHO And UN Sponsored Genocide
• Journalist Fired Over Flu Pandemic Lawsuit
• Swine Flu Hype: Political Lies and
  Media Disinformation are Rampant
• Inoculations Are The True
  Weapons Of Mass Destruction
• Baxter Caught Shipping Vaccines With
  Live Avian Flu Virus To 18 Countries Worldwide
• Federal U.S. Laws Will Make Dangerous
  Vaccinations Mandatory For All Americans
• Speculations of Origins of Swine
  Flu Proliferate Across Internet
• The Risks Of Vaccines Currently
  Outweigh Any Benefits To Human Health

Reference Source 220
September 21, 2009

...............................................................................................................